Skip to main content
. 2013 Oct 26;39(3):465–473. doi: 10.1007/s12639-013-0374-6

Table 1.

Effect of P. lentiscus mastic on the in vitro growth T. vaginalis trophozoites (106) at different incubation periods

Dosage of treatment After 24 h After 48 h After 72 h After 96 h
(Trophozoites number)
Mean ± SD
% of growth inhibition (Trophozoites number)
Mean ± SD
% of growth inhibition (Trophozoites number)
Mean ± SD
% of growth inhibition (Trophozoites number)
Mean ± SD
% of growth inhibition
Parasite control (2.10–2.36)
2.23 ± 0.13
0 (3.96–4.36)
4.16 ± 0.20
0 (11.28–11.52)
11.4 ± 0.12
0 (4.94–5.16)
5.05 ± 0.11
0
Metronidazole, 20 μg (0.78–0.82)
0.8 ± 0.02*
64.1 (0.07–0.73)
0.4 ± 0.33*
90.4 (0.03–0.17)
0.1 ± 0.07*
99.1 0.00* 100
Metronidazole, 40 μg 0.00* 100 0.00* 100 0.00* 100 0.00* 100
Solvent control (2.05–2.35)
2.2 ± 0.15
1.3 (4.00–4.22)
4.11 ± 0.11
1.2 (11.2–11.4)
11.3 ± 0.1
0.9 (4.91–5.09)
5.0 ± 0.09
1
Pistacia lentiscus mastic, 5 mg/ml (1.18–1.32)
1.25 ± 0.07*,•
44 (0.58–0.62)
0.6 ± 0.02*,•
85.6 (0.25–0.55)
0.4 ± 0.15*,•
96.4 0.00* 100
Pistacia lentiscus mastic,10 mg/ml (0.1–0.35)
0.225 ± 0.125*,•
90 0.00*,• 100 0.00*,• 100 0.00* 100
Pistacia lentiscus mastic, 15 mg/ml 0.00*,** 100 0.00*,• 100 0.00*,• 100 0.00* 100

SD standard deviation

p < 0.05, statistically significant difference in comparison to parasite control in the same time interval; ** p < 0.05, statistically significant difference in comparison to metronidazole 20 μg in the same time interval;  no statistically significant difference (p > 0.05) in comparison to metronidazole 20 μg

HHS Vulnerability Disclosure